A combination of two cancer drugs could be effective against malignant peripheral nerve sheath tumors (MPNSTs) - soft tissue tumors that are stubbornly resistant to chemotherapy and radiation - ...
The focus of this month’s blog post is a discussion of malignant peripheral nerve sheath tumors (MPNSTs), which represent one of the few potentially life-threatening complications of neurofibromatosis ...
Correlation of Snail expression and survival in patients with early-stage triple-negative breast cancer (TNBC). Background: Malignant peripheral nerve sheath tumors (MPNST) constitute a group of ...
Combining a pair of experimental drugs may help treat malignant peripheral nerve sheath tumors with fewer harmful side effects, according to preliminary animal studies. Combining a pair of ...
Neurofibromatosis type 1 (NF1) is a common genetic condition, affecting 1 in 3000 individuals, and people with NF1 are at greater risk of developing a rare, aggressive form of cancer. Diagnosing ...
Very few people, other than professionals and those close to the young people who have this rare form of cancer have ever heard of a malignant peripheral nerve sheath tumor (MPNST). Across the United ...
SHELTON, Conn., June 30, 2025 /PRNewswire/ -- Intensity Therapeutics, Inc. (Nasdaq: INTS) ("Intensity" or "the Company"), a late-stage clinical biotechnology company focused on the discovery and ...
What caused an otherwise healthy 23-year-old man to suddenly develop a large painless mass on the left side of his neck? That's what Jianyong Zhang, MD, and Xin Zhu, MM, of Guizhou Provincial People's ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results